16th Annual Scientific Meeting - Heart Failure Society of America
16th Annual Scientific Meeting - Heart Failure Society of America
16th Annual Scientific Meeting - Heart Failure Society of America
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Sept. 11<br />
Tuesday<br />
PM<br />
SYMPOSIUM<br />
Tuesday, September 11<br />
2:00-3:30 PM<br />
Ballroom 6C<br />
SYMPOSIUM<br />
Tuesday, September 11<br />
2:00-3:30 PM<br />
<strong>Meeting</strong> Room 612<br />
Sept. 11<br />
Tuesday<br />
PM<br />
Back in the Hospital<br />
Therapies in Development<br />
Moderators: Alan Jansujwicz, Bangor, ME<br />
Debra K. Moser, Lexington, KY<br />
Moderators: Steven Goldman, Tucson, AZ<br />
Michael J. Sole, Toronto, ON, Canada<br />
2:00 Leading Up to Admission (ADHERE)<br />
Javed Butler, Atlanta, GA<br />
2:00* Where is there a Clinical Need?<br />
Arthur M. Feldman, Philadelphia, PA<br />
2:15 Why is the Patient Back?<br />
Jason W. Ryan, Farmington, CT<br />
2:18* PKC Inhibitors are Ready for <strong>Heart</strong> <strong>Failure</strong> Trials!<br />
Jeffrey D. Molkentin, Cincinnati, OH<br />
Tuesday<br />
2:25 How is Comorbidity Associated with Readmission?<br />
Jill Howie Esquivel, San Francisco, CA<br />
2:35 What Else Can DOSE and ASCEND Teach Us?<br />
G. Michael Felker, Durham, NC<br />
2:45 ED Decision: Admit or Discharge to Early Follow-Up<br />
Peter S. Pang, Chicago, IL<br />
3:00 How Much Patient Education and When?<br />
Lorraine S. Evangelista, Los Angeles, CA<br />
2:36* Enough with the Kinases; Phosphatase Inhibitors for<br />
<strong>Heart</strong> <strong>Failure</strong> Therapy<br />
Yibin Wang, Los Angeles, CA<br />
2:54* Cell-Free Regenerative Therapies<br />
Annarosa Leri, Boston, MA<br />
3:12* Angiogenesis for Ischemic <strong>Heart</strong> Disease<br />
Douglas W. Losordo, Chicago, IL<br />
*15 minute presentation, 3 minute discussion<br />
Tuesday<br />
3:15 Panel Discussion<br />
Learning Objective: Describe emerging therapies for heart<br />
failure and how they might be used to improve patient care.<br />
Learning Objective: Describe factors affecting readmission<br />
<strong>of</strong> patients with heart failure and implement strategies to<br />
improve readmission rates.<br />
3:30 C<strong>of</strong>fee Break<br />
Refreshments served in Exhibit Hall 4B<br />
3:30 C<strong>of</strong>fee Break<br />
Refreshments served in Exhibit Hall 4B<br />
108 109
Change language